PUBLISHER: Fairfield Market Research | PRODUCT CODE: 2029196
PUBLISHER: Fairfield Market Research | PRODUCT CODE: 2029196
Eubiotics Market Insights, Competitive Landscape, and Market Forecast - 2033
The global eubiotics market is witnessing notable expansion as the animal nutrition industry increasingly prioritizes sustainable and antibiotic-free solutions. Eubiotics, encompassing prebiotics, probiotics, organic acids, and related feed additives, play a crucial role in improving gut health, enhancing nutrient absorption, and strengthening immunity in livestock. With growing regulatory pressure to limit antibiotic usage in animal feed, the shift toward natural growth promoters has accelerated significantly. The market is projected to reach US$ 6.1 billion in 2026 and is expected to grow to US$ 10.6 billion by 2033, registering a CAGR of 8.30% over the forecast period. This growth trajectory underscores the increasing importance of efficient and safe feed solutions in modern livestock production.
Market Insights
Eubiotics have become an essential component of advanced animal nutrition strategies, offering benefits that extend beyond growth promotion to include disease prevention and improved feed efficiency. The market is gaining traction across poultry, swine, and ruminant segments, where maintaining optimal gut microbiota is critical for productivity. Technological innovations in microbial strains, enzyme integration, and feed formulation are enhancing the performance and consistency of eubiotics. Additionally, producers are adopting tailored solutions designed to meet species-specific requirements, further boosting market penetration. The ongoing transition toward precision livestock farming is also supporting the demand for targeted nutritional interventions such as eubiotics.
Drivers
The primary factor driving the eubiotics market is the global reduction in antibiotic growth promoters due to regulatory bans and rising health concerns. Governments and food safety authorities are promoting the adoption of natural feed additives to ensure safer animal-derived products. Increasing consumer awareness regarding the quality and safety of meat, dairy, and poultry products is encouraging producers to shift toward antibiotic-free production systems.
Another key driver is the rising incidence of livestock diseases, which has emphasized the need for improved immunity and disease resistance. Eubiotics contribute to better gut health, which directly impacts overall animal performance and reduces dependency on medicinal interventions. Furthermore, the growing global demand for animal protein, fueled by population growth and urbanization, is increasing pressure on producers to enhance productivity efficiently. Eubiotics help achieve this by improving feed conversion ratios and supporting sustainable farming practices.
Business Opportunity
The eubiotics market offers substantial opportunities for innovation and strategic growth. Companies are actively investing in research and development to create advanced formulations that deliver precise functional benefits, such as enhanced digestion, improved immunity, and higher yield. The integration of biotechnology and microbiome research is enabling the development of next-generation eubiotics with improved efficacy.
Emerging economies present lucrative growth prospects due to expanding livestock production and increasing adoption of modern feeding practices. The rising popularity of organic farming and clean-label products is further driving demand for natural feed additives. Additionally, collaborations between feed manufacturers, biotechnology firms, and research institutions are accelerating product innovation and market expansion. The development of customized solutions tailored to regional and species-specific needs is expected to unlock new revenue streams.
Region Analysis
North America holds a significant share of the eubiotics market, supported by strict regulations on antibiotic usage and a high level of awareness among livestock producers. The region's focus on animal welfare and advanced farming practices continues to drive demand for high-quality feed additives.
Europe represents a mature market, characterized by stringent regulatory frameworks and strong adoption of sustainable animal nutrition solutions. The early implementation of antibiotic bans has positioned the region as a leader in eubiotics usage.
Asia Pacific is anticipated to register the fastest growth during the forecast period, driven by its large livestock population and increasing demand for protein-rich diets. Rapid industrialization of the livestock sector and rising investments in feed quality are supporting market expansion in countries such as China and India.
South America is experiencing steady growth, particularly in the poultry and beef sectors, where the need for efficient feed solutions is high. The adoption of eubiotics is increasing as producers seek to improve productivity and meet export standards.
The Middle East and Africa are emerging markets with growing potential, supported by rising investments in livestock farming and increasing awareness about animal health. While adoption levels are currently moderate, favorable government initiatives and improving infrastructure are expected to drive future growth.
Key Players
- Cargill, Incorporated
- Archer Daniels Midland Company (ADM)
- BASF SE
- dsm-firmenich
- Evonik Industries AG
- Novozymes A/S (Novonesis)
- Kemin Industries, Inc.
- Chr. Hansen Holding A/S
- Lallemand Inc.
- Lesaffre Group
- Novus International, Inc.
- DuPont de Nemours, Inc.
- Beneo GmbH
- ADDCON GmbH
- Nutreco N.V.
Segmentation
By Type
- Prebiotics
- Probiotics
- Organic Acids
- Others
By Animal Type
- Ruminants
- Poultry
- Swine
- Others
By Form
- Dry
- Liquid
By Function
- Nutrition & Gut
- Yield
- Immunity
By Geography
- North America
- Europe
- Asia Pacific
- South America
- Middle East & Africa
Table of Contents
1. Executive Summary
- 1.1. Global Eubiotics Market Snapshot
- 1.2. Future Projections
- 1.3. Key Market Trends
- 1.4. Regional Snapshot, by Value, 2026
- 1.5. Analyst Recommendations
2. Market Overview
- 2.1. Market Definitions and Segmentations
- 2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
- 2.3. Value Chain Analysis
- 2.4. COVID-19 Impact Analysis
- 2.5. Porter's Five Forces Analysis
- 2.6. Impact of Russia-Ukraine Conflict
- 2.7. PESTLE Analysis
- 2.8. Regulatory Analysis
- 2.9. Price Trend Analysis
- 2.9.1. Current Prices and Future Projections, 2025-2033
- 2.9.2. Price Impact Factors
3. Global Eubiotics Market Outlook, 2020-2033
- 3.1. Global Eubiotics Market Outlook, by Type, Value (US$ Bn), 2020-2033
- 3.1.1. Prebiotics
- 3.1.2. Probiotics
- 3.1.3. Organic Acids
- 3.1.4. Others
- 3.2. Global Eubiotics Market Outlook, by Form, Value (US$ Bn), 2020-2033
- 3.2.1. Dry
- 3.2.2. Liquid
- 3.3. Global Eubiotics Market Outlook, by Animal Type, Value (US$ Bn), 2020-2033
- 3.3.1. Ruminants
- 3.3.2. Poultry
- 3.3.3. Swine
- 3.3.4. Others
- 3.4. Global Eubiotics Market Outlook, by Function, Value (US$ Bn), 2020-2033
- 3.4.1. Nutrition & Gut
- 3.4.2. Yield
- 3.4.3. Immunity
- 3.5. Global Eubiotics Market Outlook, by Region, Value (US$ Bn), 2020-2033
- 3.5.1. North America
- 3.5.2. Europe
- 3.5.3. Asia Pacific
- 3.5.4. Latin America
- 3.5.5. Middle East & Africa
4. North America Eubiotics Market Outlook, 2020-2033
- 4.1. North America Eubiotics Market Outlook, by Type, Value (US$ Bn), 2020-2033
- 4.1.1. Prebiotics
- 4.1.2. Probiotics
- 4.1.3. Organic Acids
- 4.1.4. Others
- 4.2. North America Eubiotics Market Outlook, by Form, Value (US$ Bn), 2020-2033
- 4.2.1. Dry
- 4.2.2. Liquid
- 4.3. North America Eubiotics Market Outlook, by Animal Type, Value (US$ Bn), 2020-2033
- 4.3.1. Ruminants
- 4.3.2. Poultry
- 4.3.3. Swine
- 4.3.4. Others
- 4.4. North America Eubiotics Market Outlook, by Function, Value (US$ Bn), 2020-2033
- 4.4.1. Nutrition & Gut
- 4.4.2. Yield
- 4.4.3. Immunity
- 4.5. North America Eubiotics Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 4.5.1. U.S. Eubiotics Market Outlook, by Type, 2020-2033
- 4.5.2. U.S. Eubiotics Market Outlook, by Form, 2020-2033
- 4.5.3. U.S. Eubiotics Market Outlook, by Animal Type, 2020-2033
- 4.5.4. U.S. Eubiotics Market Outlook, by Function, 2020-2033
- 4.5.5. Canada Eubiotics Market Outlook, by Type, 2020-2033
- 4.5.6. Canada Eubiotics Market Outlook, by Form, 2020-2033
- 4.5.7. Canada Eubiotics Market Outlook, by Animal Type, 2020-2033
- 4.5.8. Canada Eubiotics Market Outlook, by Function, 2020-2033
- 4.6. BPS Analysis/Market Attractiveness Analysis
5. Europe Eubiotics Market Outlook, 2020-2033
- 5.1. Europe Eubiotics Market Outlook, by Type, Value (US$ Bn), 2020-2033
- 5.1.1. Prebiotics
- 5.1.2. Probiotics
- 5.1.3. Organic Acids
- 5.1.4. Others
- 5.2. Europe Eubiotics Market Outlook, by Form, Value (US$ Bn), 2020-2033
- 5.2.1. Dry
- 5.2.2. Liquid
- 5.3. Europe Eubiotics Market Outlook, by Animal Type, Value (US$ Bn), 2020-2033
- 5.3.1. Ruminants
- 5.3.2. Poultry
- 5.3.3. Swine
- 5.3.4. Others
- 5.4. Europe Eubiotics Market Outlook, by Function, Value (US$ Bn), 2020-2033
- 5.4.1. Nutrition & Gut
- 5.4.2. Yield
- 5.4.3. Immunity
- 5.5. Europe Eubiotics Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 5.5.1. Germany Eubiotics Market Outlook, by Type, 2020-2033
- 5.5.2. Germany Eubiotics Market Outlook, by Form, 2020-2033
- 5.5.3. Germany Eubiotics Market Outlook, by Animal Type, 2020-2033
- 5.5.4. Germany Eubiotics Market Outlook, by Function, 2020-2033
- 5.5.5. Italy Eubiotics Market Outlook, by Type, 2020-2033
- 5.5.6. Italy Eubiotics Market Outlook, by Form, 2020-2033
- 5.5.7. Italy Eubiotics Market Outlook, by Animal Type, 2020-2033
- 5.5.8. Italy Eubiotics Market Outlook, by Function, 2020-2033
- 5.5.9. France Eubiotics Market Outlook, by Type, 2020-2033
- 5.5.10. France Eubiotics Market Outlook, by Form, 2020-2033
- 5.5.11. France Eubiotics Market Outlook, by Animal Type, 2020-2033
- 5.5.12. France Eubiotics Market Outlook, by Function, 2020-2033
- 5.5.13. U.K. Eubiotics Market Outlook, by Type, 2020-2033
- 5.5.14. U.K. Eubiotics Market Outlook, by Form, 2020-2033
- 5.5.15. U.K. Eubiotics Market Outlook, by Animal Type, 2020-2033
- 5.5.16. U.K. Eubiotics Market Outlook, by Function, 2020-2033
- 5.5.17. Spain Eubiotics Market Outlook, by Type, 2020-2033
- 5.5.18. Spain Eubiotics Market Outlook, by Form, 2020-2033
- 5.5.19. Spain Eubiotics Market Outlook, by Animal Type, 2020-2033
- 5.5.20. Spain Eubiotics Market Outlook, by Function, 2020-2033
- 5.5.21. Russia Eubiotics Market Outlook, by Type, 2020-2033
- 5.5.22. Russia Eubiotics Market Outlook, by Form, 2020-2033
- 5.5.23. Russia Eubiotics Market Outlook, by Animal Type, 2020-2033
- 5.5.24. Russia Eubiotics Market Outlook, by Function, 2020-2033
- 5.5.25. Rest of Europe Eubiotics Market Outlook, by Type, 2020-2033
- 5.5.26. Rest of Europe Eubiotics Market Outlook, by Form, 2020-2033
- 5.5.27. Rest of Europe Eubiotics Market Outlook, by Animal Type, 2020-2033
- 5.5.28. Rest of Europe Eubiotics Market Outlook, by Function, 2020-2033
- 5.6. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Eubiotics Market Outlook, 2020-2033
- 6.1. Asia Pacific Eubiotics Market Outlook, by Type, Value (US$ Bn), 2020-2033
- 6.1.1. Prebiotics
- 6.1.2. Probiotics
- 6.1.3. Organic Acids
- 6.1.4. Others
- 6.2. Asia Pacific Eubiotics Market Outlook, by Form, Value (US$ Bn), 2020-2033
- 6.2.1. Dry
- 6.2.2. Liquid
- 6.3. Asia Pacific Eubiotics Market Outlook, by Animal Type, Value (US$ Bn), 2020-2033
- 6.3.1. Ruminants
- 6.3.2. Poultry
- 6.3.3. Swine
- 6.3.4. Others
- 6.4. Asia Pacific Eubiotics Market Outlook, by Function, Value (US$ Bn), 2020-2033
- 6.4.1. Nutrition & Gut
- 6.4.2. Yield
- 6.4.3. Immunity
- 6.5. Asia Pacific Eubiotics Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 6.5.1. China Eubiotics Market Outlook, by Type, 2020-2033
- 6.5.2. China Eubiotics Market Outlook, by Form, 2020-2033
- 6.5.3. China Eubiotics Market Outlook, by Animal Type, 2020-2033
- 6.5.4. China Eubiotics Market Outlook, by Function, 2020-2033
- 6.5.5. Japan Eubiotics Market Outlook, by Type, 2020-2033
- 6.5.6. Japan Eubiotics Market Outlook, by Form, 2020-2033
- 6.5.7. Japan Eubiotics Market Outlook, by Animal Type, 2020-2033
- 6.5.8. Japan Eubiotics Market Outlook, by Function, 2020-2033
- 6.5.9. South Korea Eubiotics Market Outlook, by Type, 2020-2033
- 6.5.10. South Korea Eubiotics Market Outlook, by Form, 2020-2033
- 6.5.11. South Korea Eubiotics Market Outlook, by Animal Type, 2020-2033
- 6.5.12. South Korea Eubiotics Market Outlook, by Function, 2020-2033
- 6.5.13. India Eubiotics Market Outlook, by Type, 2020-2033
- 6.5.14. India Eubiotics Market Outlook, by Form, 2020-2033
- 6.5.15. India Eubiotics Market Outlook, by Animal Type, 2020-2033
- 6.5.16. India Eubiotics Market Outlook, by Function, 2020-2033
- 6.5.17. Southeast Asia Eubiotics Market Outlook, by Type, 2020-2033
- 6.5.18. Southeast Asia Eubiotics Market Outlook, by Form, 2020-2033
- 6.5.19. Southeast Asia Eubiotics Market Outlook, by Animal Type, 2020-2033
- 6.5.20. Southeast Asia Eubiotics Market Outlook, by Function, 2020-2033
- 6.5.21. Rest of SAO Eubiotics Market Outlook, by Type, 2020-2033
- 6.5.22. Rest of SAO Eubiotics Market Outlook, by Form, 2020-2033
- 6.5.23. Rest of SAO Eubiotics Market Outlook, by Animal Type, 2020-2033
- 6.5.24. Rest of SAO Eubiotics Market Outlook, by Function, 2020-2033
- 6.6. BPS Analysis/Market Attractiveness Analysis
7. Latin America Eubiotics Market Outlook, 2020-2033
- 7.1. Latin America Eubiotics Market Outlook, by Type, Value (US$ Bn), 2020-2033
- 7.1.1. Prebiotics
- 7.1.2. Probiotics
- 7.1.3. Organic Acids
- 7.1.4. Others
- 7.2. Latin America Eubiotics Market Outlook, by Form, Value (US$ Bn), 2020-2033
- 7.2.1. Dry
- 7.2.2. Liquid
- 7.3. Latin America Eubiotics Market Outlook, by Animal Type, Value (US$ Bn), 2020-2033
- 7.3.1. Ruminants
- 7.3.2. Poultry
- 7.3.3. Swine
- 7.3.4. Others
- 7.4. Latin America Eubiotics Market Outlook, by Function, Value (US$ Bn), 2020-2033
- 7.4.1. Nutrition & Gut
- 7.4.2. Yield
- 7.4.3. Immunity
- 7.5. Latin America Eubiotics Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 7.5.1. Brazil Eubiotics Market Outlook, by Type, 2020-2033
- 7.5.2. Brazil Eubiotics Market Outlook, by Form, 2020-2033
- 7.5.3. Brazil Eubiotics Market Outlook, by Animal Type, 2020-2033
- 7.5.4. Brazil Eubiotics Market Outlook, by Function, 2020-2033
- 7.5.5. Mexico Eubiotics Market Outlook, by Type, 2020-2033
- 7.5.6. Mexico Eubiotics Market Outlook, by Form, 2020-2033
- 7.5.7. Mexico Eubiotics Market Outlook, by Animal Type, 2020-2033
- 7.5.8. Mexico Eubiotics Market Outlook, by Function, 2020-2033
- 7.5.9. Argentina Eubiotics Market Outlook, by Type, 2020-2033
- 7.5.10. Argentina Eubiotics Market Outlook, by Form, 2020-2033
- 7.5.11. Argentina Eubiotics Market Outlook, by Animal Type, 2020-2033
- 7.5.12. Argentina Eubiotics Market Outlook, by Function, 2020-2033
- 7.5.13. Rest of LATAM Eubiotics Market Outlook, by Type, 2020-2033
- 7.5.14. Rest of LATAM Eubiotics Market Outlook, by Form, 2020-2033
- 7.5.15. Rest of LATAM Eubiotics Market Outlook, by Animal Type, 2020-2033
- 7.5.16. Rest of LATAM Eubiotics Market Outlook, by Function, 2020-2033
- 7.6. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Eubiotics Market Outlook, 2020-2033
- 8.1. Middle East & Africa Eubiotics Market Outlook, by Type, Value (US$ Bn), 2020-2033
- 8.1.1. Prebiotics
- 8.1.2. Probiotics
- 8.1.3. Organic Acids
- 8.1.4. Others
- 8.2. Middle East & Africa Eubiotics Market Outlook, by Form, Value (US$ Bn), 2020-2033
- 8.2.1. Dry
- 8.2.2. Liquid
- 8.3. Middle East & Africa Eubiotics Market Outlook, by Animal Type, Value (US$ Bn), 2020-2033
- 8.3.1. Ruminants
- 8.3.2. Poultry
- 8.3.3. Swine
- 8.3.4. Others
- 8.4. Middle East & Africa Eubiotics Market Outlook, by Function, Value (US$ Bn), 2020-2033
- 8.4.1. Nutrition & Gut
- 8.4.2. Yield
- 8.4.3. Immunity
- 8.5. Middle East & Africa Eubiotics Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 8.5.1. GCC Eubiotics Market Outlook, by Type, 2020-2033
- 8.5.2. GCC Eubiotics Market Outlook, by Form, 2020-2033
- 8.5.3. GCC Eubiotics Market Outlook, by Animal Type, 2020-2033
- 8.5.4. GCC Eubiotics Market Outlook, by Function, 2020-2033
- 8.5.5. South Africa Eubiotics Market Outlook, by Type, 2020-2033
- 8.5.6. South Africa Eubiotics Market Outlook, by Form, 2020-2033
- 8.5.7. South Africa Eubiotics Market Outlook, by Animal Type, 2020-2033
- 8.5.8. South Africa Eubiotics Market Outlook, by Function, 2020-2033
- 8.5.9. Egypt Eubiotics Market Outlook, by Type, 2020-2033
- 8.5.10. Egypt Eubiotics Market Outlook, by Form, 2020-2033
- 8.5.11. Egypt Eubiotics Market Outlook, by Animal Type, 2020-2033
- 8.5.12. Egypt Eubiotics Market Outlook, by Function, 2020-2033
- 8.5.13. Nigeria Eubiotics Market Outlook, by Type, 2020-2033
- 8.5.14. Nigeria Eubiotics Market Outlook, by Form, 2020-2033
- 8.5.15. Nigeria Eubiotics Market Outlook, by Animal Type, 2020-2033
- 8.5.16. Nigeria Eubiotics Market Outlook, by Function, 2020-2033
- 8.5.17. Rest of Middle East Eubiotics Market Outlook, by Type, 2020-2033
- 8.5.18. Rest of Middle East Eubiotics Market Outlook, by Form, 2020-2033
- 8.5.19. Rest of Middle East Eubiotics Market Outlook, by Animal Type, 2020-2033
- 8.5.20. Rest of Middle East Eubiotics Market Outlook, by Function, 2020-2033
- 8.6. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
- 9.1. Company Vs Segment Heatmap
- 9.2. Company Market Share Analysis, 2025
- 9.3. Competitive Dashboard
- 9.4. Company Profiles
- 9.4.1. Cargill, Incorporated
- 9.4.1.1. Company Overview
- 9.4.1.2. Product Portfolio
- 9.4.1.3. Financial Overview
- 9.4.1.4. Business Strategies and Developments
- 9.4.2. Archer Daniels Midland Company (ADM)
- 9.4.3. BASF SE
- 9.4.4. dsm-firmenich
- 9.4.5. Evonik Industries AG
- 9.4.6. Novozymes A/S (Novonesis)
- 9.4.7. Kemin Industries, Inc.
- 9.4.8. Chr. Hansen Holding A/S
- 9.4.9. Lallemand Inc.
- 9.4.10. Lesaffre Group
- 9.4.1. Cargill, Incorporated
10. Appendix
- 10.1. Research Methodology
- 10.2. Report Assumptions
- 10.3. Acronyms and Abbreviations
